twitter
facebook
Wednesday, February 10, 04:28 am IST
Hot Searches:  Jubilant FoodWorks, debt crisis, budget
| Feedback
Moneycontrol » News Center » Business » Business News

Want news about Aurobindo Pharma to land in your mailbox?

Set an alert here

Aurobindo gets approval for Abacavir Sulfate/Lamivudine tab

Published on Mon, Dec 22, 2008 at 13:33   |  Updated at Mon, Dec 22, 2008 at 15:45  |  Source : Moneycontrol.com
Email
Print
Blish This

Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market fixed dosed combination Abacavir Sulfate / Lamivudine Tablets 60/30mg from the US Food & Drug Administration (USFDA).

 

The New Drug Application (NDA) 22-295 provides for the use of Abacavir Sulfate / Lamivudine Tablets 60/30mg for the treatment of HIV infections.


 

The company had earlier received tentative approvals to Co-Packaged Lamivudine / Zidovudine Tablets + Abacavir Sulfate Tablets 150/300mg + 300mg and Abacavir Sulfate / Lamivudine Tablets 600/300 mg

 

This is Aurobindo’s 87th ANDA approval from USFDA (61 Final approvals, 26 Tentative approvals). 

 

Sourced From: Aurobindo Pharma Limited

Help us develop News Center
Tell us what you want!
CEO Wall See All

Harsh Manglik

Harsh Manglik

Chairman

Accenture India

Accenture India to hire aggressively for select verticals

Vishal Doshi

Vishal Doshi

Managing Director

Shrenju & Company

Shrenuj & Company will project 15% rev rise this yr

MP Taparia

MP Taparia

Chairman

Supreme Petrochemicals

Supreme Petrochemicals expects Rs 2200cr rev in next 1.5yrs

Vineet Nayyar

Vineet Nayyar

Chief Executive Officer

HCL Technologies

HCL Tech plans to merge arms with itself, eyes new spots

WHAT OTHERS LIKE
  • Most Read
  • Most Viewed
24 Hours
7 Days
1 Month
NEWS FROM OUR PARTNERS
©Network 18, 2010. All Rights Reserved